ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages BELLUS Health Inc. Investors with Losses to Secure Counsel Before Important May 17 Deadline in Securities Class Action - BLU Biotech Investing
Amgen's Investigational Targeted Treatment Bemarituzumab Granted Breakthrough Therapy Designation Biotech Investing
Early Warning Report Issued Pursuant to National Instrument 62-103 in Connection with the Closing of the Qualifying Transaction of Cloud DX Inc. Life Science Investing
SHRMF Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Champignon Brands Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm Psychedelics Investing
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Champignon Brands Inc. Investors Psychedelics Investing
PLUG, WKHS & BLU Class Action Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm Biotech Investing
Perimeter Medical Imaging AI to Present at 2021 Bloom Burton & Co. Healthcare Investor Conference Medical Device Investing
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
